Basic Materials / Specialty ChemicalsNSE
$596.00
-6.85 (-1.14%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $262.6M · quality 50.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.5B
P/E
139.3x
↑EV/EBITDA
38.8x
↑ROE
2.1%
↑Gross Margin
20.1%
↓Debt/Equity
0.32
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
-10.7%
FCF CAGR
-9.0%
FCF margin
5.7%
FCF / Net income
4.74x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.60B · net income $55.4M · FCF $262.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.60B | $4.60B | $5.38B | $6.18B | $6.46B |
| Net Income | $55.4M | $55.4M | $219.7M | $405.0M | $435.0M |
| EBITDA | $220.4M | $220.4M | $441.2M | $681.1M | $730.1M |
| EPS | 4.28 | 4.28 | 16.88 | 31.10 | 33.41 |
| Gross Margin | 20.1% | 20.1% | 25.3% | 18.3% | 17.5% |
| Operating Margin | 2.3% | 2.3% | 6.0% | 9.3% | 9.9% |
| Net Margin | 1.2% | 1.2% | 4.1% | 6.6% | 6.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.32 | 0.32 | 0.21 | 0.03 | 0.19 |
| Current Ratio | 1.65 | 1.65 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $262.6M | $262.6M | $-428.9M | $563.5M | $348.9M |
| Returns | |||||
| ROE | 2.1% | 2.1% | 7.3% | 14.0% | 16.8% |
| Valuation | |||||
| P/E | 139.25 | 139.25 | 52.33 | 41.55 | 30.89 |
| EV/EBITDA | 38.81 | 38.81 | 27.49 | 24.81 | 19.09 |
| P/B | 2.93 | 2.93 | 3.81 | 5.80 | 5.18 |
| Growth & Yield | |||||
| Revenue Growth | -14.5% | -14.5% | -13.0% | -4.3% | — |
| EPS Growth | -74.6% | -74.6% | -45.7% | -6.9% | — |
| Dividend Yield | 0.2% | 0.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
131.2%
EPS terminal req.
$52.89
Spread vs growth
-205.8%
5Y implied EPS CAGR
71.8%
EPS terminal req.
$63.99
Spread vs growth
-146.4%
10Y implied EPS CAGR
37.5%
EPS terminal req.
$103.06
Spread vs growth
-112.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-28.9%
Start / end P/E
49.8x → 139.3x
EPS bridge
16.88 → 4.28
Residual
-134.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.